BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma S, Odunsi K, Driscoll D, Lele S. Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer. 2005;15:475-482. [PMID: 15882172 DOI: 10.1111/j.1525-1438.2005.15311.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmadi N, Tan K, Solomon MJ, Al-mozany N, Carter J. Pelvic Exenteration for Primary and Recurrent Gynecologic Malignancies Is Safe and Achieves Acceptable Long-Term Outcomes. Journal of Gynecologic Surgery 2014;30:255-9. [DOI: 10.1089/gyn.2013.0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Domenici L, Nixon K, Sorbi F, Kyrgiou M, Yazbek J, Hall M, Campbell J, Gibbons N, Park WE, Gabra H, Fotopoulou C. Surgery for Recurrent Uterine Cancer: Surgical Outcomes and Implications for Survival—A Case Series. Int J Gynecol Cancer 2017;27:759-67. [DOI: 10.1097/igc.0000000000000936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Maggioni A, Roviglione G, Landoni F, Zanagnolo V, Peiretti M, Colombo N, Bocciolone L, Biffi R, Minig L, Morrow CP. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 2009;114:64-8. [PMID: 19411097 DOI: 10.1016/j.ygyno.2009.03.029] [Cited by in Crossref: 101] [Cited by in F6Publishing: 64] [Article Influence: 8.4] [Reference Citation Analysis]
4 Bansal N, Roberts WS, Apte SM, Lancaster JM, Wenham RM. Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations. J Surg Oncol 2009;100:511-4. [PMID: 19697350 DOI: 10.1002/jso.21372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol 2006;102:534-6. [PMID: 16483643 DOI: 10.1016/j.ygyno.2006.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
6 Baiocchi G, Guimaraes GC, Faloppa CC, Kumagai LY, Oliveira RAR, Begnami MD, Soares FA, Lopes A. Does Histologic Type Correlate to Outcome after Pelvic Exenteration for Cervical and Vaginal Cancer? Ann Surg Oncol 2013;20:1694-700. [DOI: 10.1245/s10434-012-2768-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. European Journal of Surgical Oncology (EJSO) 2015;41:975-85. [DOI: 10.1016/j.ejso.2015.03.235] [Cited by in Crossref: 45] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
8 Hope JM, Pothuri B. The role of palliative surgery in gynecologic cancer cases. Oncologist 2013;18:73-9. [PMID: 23299775 DOI: 10.1634/theoncologist.2012-0328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Feddock J, Cheek D, Steber C, Edwards J, Slone S, Luo W, Randall M. Reirradiation Using Permanent Interstitial Brachytherapy: A Potentially Durable Technique for Salvaging Recurrent Pelvic Malignancies. Int J Radiat Oncol Biol Phys 2017;99:1225-33. [PMID: 29029888 DOI: 10.1016/j.ijrobp.2017.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
10 Ungar L, Palfalvi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol 2008;111:S9-12. [PMID: 18775558 DOI: 10.1016/j.ygyno.2008.07.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
11 Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol 2014;134:546-51. [PMID: 25014540 DOI: 10.1016/j.ygyno.2014.06.034] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 6.9] [Reference Citation Analysis]
12 Kuhrt MP, Chokshi RJ, Arrese D, Martin EW Jr. Retrospective review of pelvic malignancies undergoing total pelvic exenteration. World J Surg Oncol 2012;10:110. [PMID: 22703863 DOI: 10.1186/1477-7819-10-110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 Jäger L, Nilsson PJ, Rådestad AF. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution. Int J Gynecol Cancer 2013;23:755-62. [PMID: 23407096 DOI: 10.1097/IGC.0b013e318287a874] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
14 de Wilt JH, van Leeuwen DH, Logmans A, Verhoef C, Kirkels WJ, Vermaas M, Ansink AC. Pelvic exenteration for primary and recurrent gynaecological malignancies. European Journal of Obstetrics & Gynecology and Reproductive Biology 2007;134:243-8. [DOI: 10.1016/j.ejogrb.2006.07.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
15 Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol 2011;122:14-8. [PMID: 21444105 DOI: 10.1016/j.ygyno.2011.03.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
16 Höckel M, Dornhöfer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. The Lancet Oncology 2006;7:837-47. [DOI: 10.1016/s1470-2045(06)70903-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 10] [Article Influence: 8.3] [Reference Citation Analysis]
17 Park J, Choi HJ, Jeong S, Chung J, Park JK, Park S. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival. J Surg Oncol 2007;96:560-8. [DOI: 10.1002/jso.20847] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
18 Pathiraja P, Sandhu H, Instone M, Haldar K, Kehoe S. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered? Arch Gynecol Obstet 2014;289:657-62. [PMID: 24026090 DOI: 10.1007/s00404-013-3023-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Guimarães GC, Baiocchi G, Ferreira FO, Kumagai LY, Fallopa CC, Aguiar S, Rossi BM, Soares FA, Lopes A. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet 2011;283:1107-12. [DOI: 10.1007/s00404-010-1544-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
20 Rema P, Mathew AP, Suchetha S, Ahmed I. Salvage Surgery for Cervical Cancer Recurrences. Indian J Surg Oncol 2017;8:146-9. [PMID: 28546709 DOI: 10.1007/s13193-015-0472-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
21 Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Ferrandina G, Legge F, Parazzini F, Scambia G, Schneider A, Vercellino GF. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer 2014;24:916-22. [PMID: 24442006 DOI: 10.1097/IGC.0b013e3182a80aec] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Diver EJ, Rauh-Hain JA, Del Carmen MG. Total pelvic exenteration for gynecologic malignancies. Int J Surg Oncol 2012;2012:693535. [PMID: 22720150 DOI: 10.1155/2012/693535] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
23 Ferenschild FT, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AM, de Wilt JH. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009;33:1502-1508. [PMID: 19421811 DOI: 10.1007/s00268-009-0066-7] [Cited by in Crossref: 110] [Cited by in F6Publishing: 73] [Article Influence: 9.2] [Reference Citation Analysis]
24 Wydra D, Emerich J, Sawicki S, Ciach K, Marciniak A. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience. World J Gastroenterol 2006;12:1115-9. [PMID: 16534855 DOI: 10.3748/wjg.v12.i7.1115] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
25 Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, Schmeler KM, Frumovitz M, Ramirez PT, Soliman PT. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol 2014;132:114-8. [PMID: 24262877 DOI: 10.1016/j.ygyno.2013.11.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
26 Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol 2012;23:242-50. [PMID: 23094127 DOI: 10.3802/jgo.2012.23.4.242] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
27 Monk BJ, Tewari KS. Invasive Cervical Cancer. Clinical Gynecologic Oncology. Elsevier; 2007. pp. 55-124. [DOI: 10.1016/b978-032303978-9.50006-x] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]
28 Matsuo K, Matsuzaki S, Mandelbaum RS, Matsushima K, Klar M, Grubbs BH, Roman LD, Wright JD. Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies. J Surg Oncol 2019. [PMID: 31746006 DOI: 10.1002/jso.25770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zanfagnin V, Ferrero A, Biglia N, Aletti G, Gill SE, Makdisi PB, Multinu F, Mariani A. The role of surgery in recurrent endometrial cancer. Expert Review of Anticancer Therapy 2016;16:741-50. [DOI: 10.1080/14737140.2016.1190650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ling DC, Vargo JA, Glaser SM, Kim H, Beriwal S. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer. Gynecol Oncol 2019;152:581-6. [PMID: 30600093 DOI: 10.1016/j.ygyno.2018.12.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
31 Baiocchi G, Guimaraes G, Rosa Oliveira R, Kumagai L, Faloppa C, Aguiar S, Begnami M, Soares F, Lopes A. Prognostic factors in pelvic exenteration for gynecological malignancies. European Journal of Surgical Oncology (EJSO) 2012;38:948-54. [DOI: 10.1016/j.ejso.2012.07.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
32 Kaur M, Joniau S, D’hoore A, Van Calster B, Van Limbergen E, Leunen K, Penninckx F, Van Poppel H, Amant F, Vergote I. Pelvic Exenterations for Gynecological Malignancies: A Study of 36 Cases. International Journal of Gynecological Cancer 2012;22:889-96. [DOI: 10.1097/igc.0b013e31824eb8cd] [Cited by in Crossref: 29] [Article Influence: 3.2] [Reference Citation Analysis]
33 Martínez A, Filleron T, Vitse L, Querleu D, Mery E, Balague G, Delannes M, Soulie M, Pomel C, Ferron G. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol 2011;120:374-9. [PMID: 21215437 DOI: 10.1016/j.ygyno.2010.11.032] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
34 Forner DM, Lampe B. Intestinal Complications After Pelvic Exenterations in Gynecologic Oncology: . International Journal of Gynecological Cancer 2009;19:958-62. [DOI: 10.1111/igc.0b013e3181a3f77c] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
35 Landoni F, Zanagnolo V, Rosenberg P, Lopes A, Radice D, Bocciolone L, Aletti G, Parma G, Colombo N, Maggioni A. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience. Gynecologic Oncology 2013;130:69-74. [DOI: 10.1016/j.ygyno.2013.02.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
36 Backes FJ, Billingsley CC, Martin DD, Tierney BJ, Eisenhauer EL, Cohn DE, O'malley DM, Salani R, Copeland LJ, Fowler JM. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer? Gynecologic Oncology 2014;135:95-9. [DOI: 10.1016/j.ygyno.2014.07.093] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
37 Fotopoulou C, Neumann U, Kraetschell R, Schefold JC, Weidemann H, Lichtenegger W, Sehouli J. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies. J Surg Oncol 2010;101:507-12. [PMID: 20401918 DOI: 10.1002/jso.21518] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
38 Backes FJ, Tierney BJ, Eisenhauer EL, Bahnson RR, Cohn DE, Fowler JM. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: Time to change back? Gynecologic Oncology 2013;128:60-4. [DOI: 10.1016/j.ygyno.2012.08.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
39 Fowler JM. Incorporating pelvic/vaginal reconstruction into radical pelvic surgery. Gynecologic Oncology 2009;115:154-63. [DOI: 10.1016/j.ygyno.2009.05.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
40 Schmidt A, Imesch P, Fink D, Egger H. Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer: Clinical Outcomes of 40 Patients. Int J Gynecol Cancer 2016;26:716-21. [DOI: 10.1097/igc.0000000000000678] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 3.6] [Reference Citation Analysis]
41 Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Köhler C. Exenterations 60 Years After First Description: Results of a Survey Among US and German Gynecologic Oncology Centers. International Journal of Gynecological Cancer 2009;19:974-7. [DOI: 10.1111/igc.0b013e3181a8351e] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
42 Backes FJ, Martin DD. Intraoperative radiation therapy (IORT) for gynecologic malignancies. Gynecol Oncol. 2015;138:449-456. [PMID: 26033307 DOI: 10.1016/j.ygyno.2015.05.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecologic Oncology 2006;103:1023-30. [DOI: 10.1016/j.ygyno.2006.06.027] [Cited by in Crossref: 87] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
44 Tran PT, Su Z, Hara W, Husain A, Teng N, Kapp DS. Long-Term Survivors Using Intraoperative Radiotherapy for Recurrent Gynecologic Malignancies. International Journal of Radiation Oncology*Biology*Physics 2007;69:504-11. [DOI: 10.1016/j.ijrobp.2007.03.021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
45 Patel H, Joseph JV, Amodeo A, Kothari K. Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy? J Minim Access Surg. 2009;5:111-114. [PMID: 20407571 DOI: 10.4103/0972-9941.59310] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]